New obesity drug SGB-7342 enters first human safety trial
Disease control
Not yet recruiting
This early-stage study tests a new drug called SGB-7342 in 45 adults who are overweight or have obesity. The main goal is to check if the drug is safe and tolerable when given as a single injection under the skin. Researchers will also measure how the drug moves in the body and h…
Phase: PHASE1 • Sponsor: Suzhou Sanegene Bio Inc. • Aim: Disease control
Last updated May 17, 2026 11:53 UTC